Salicylate (choline)
Salicylate choline is an orally active derivative of Aspirin (acetylsalicylic acid). Salicylate choline significantly reduces IL-1β, IL-6, TNF-α and IL-10 levels in cells. Salicylate choline enhances the anti-tumor activity of the CRM1 inhibitor Selinexor (KPT-330) (HY-17536) through inducing S-phase cell cycle arrest and impairing DNA damage repair. Salicylate choline combined with Selinexor demonstrates excellent anti-tumor efficacy in mice xenograft model harboring JeKo-1 cells. Salicylate choline can be used for the study of rheumatic diseases, inflammation and cancer[1][2][3][4].
Product Specifications
CAS Number
2016-36-6
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative; Interleukin Related; Polo-like Kinase (PLK) ; TNF Receptor
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Others
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C(O)C1=CC=CC=C1[O-].C[N+](C)(CCO)C
Molecular Formula
C12H19NO4
Molecular Weight
241.28
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
